Fredun Pharmaceuticals Live BSE/NSE | Fredun Pharmaceuticals Fundamenta data | Fredun Pharmaceuticals Balance sheet | Fredun Pharmaceuticals Quarterly Results | Fredun Pharmaceuticals Profit & Loss

Stock Summary

Market Cap(Crs)
Stock P:E
Face Value

183.52
110.62
10

Enterprise Value(Crs)
Dividend Yield
Price:Book Value

215.37
0.14%
4.38

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

10 Years
5 Years
3 Years

30.35
21.68
23.76

EBITDA CAGR (%)

10 Years
5 Years
3 Years

27.05
16.39
7.85

PAT CAGR (%)

10 Years
5 Years
3 Years

57.68
12.17
2.78

P:E (Median)

8 Years
5 Years
3 Years

-
36.17
42.21

P:BV (Average)

8 Years
5 Years
3 Years

-
2.22
2.22

EV:EBITDA (Average)

8 Years
5 Years
3 Years

-
14.45
15.82

Quarterly Results

Standalone Figures in Rs. Crores

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 33.60 31.90 5.33% 13.74 28.32 -51.48% 25.30 32.23 -21.50% 27.86 26.56 4.89%
Expenses 30.20 29.64 1.89% 12.48 26.34 -52.62% 23.32 27.26 -14.45% 25.38 23.29 8.97%
EBITDA 3.40 2.26 50.44% 1.27 1.99 -36.18% 1.98 4.97 -60.16% 2.47 3.27 -24.46%
EBIDTM 10.11% 7.08% 9.21% 7.02% 7.84% 15.42% 8.87% 12.31%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.92 0.92 0.00% 0.77 1.29 -40.31% 1.14 1.81 -37.02% 0.98 0.59 66.10%
Depreciation 0.49 0.47 4.26% 0.46 0.46 0.00% 0.47 0.35 34.29% 0.48 0.33 45.45%
PBT 0.83 0.88 -5.68% 0.04 0.23 -82.61% 0.37 2.82 -86.88% 1.02 1.71 -40.35%
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.59 1.70 -65.29% 0.00 0.00 0.00
PAT 0.83 0.88 -5.68% 0.04 0.23 -82.61% -0.22 1.12 - 1.02 1.71 -40.35%
PATM 2.46% 2.75% 0.27% 0.82% -0.88% 3.47% 3.66% 6.43%
EPS 2.06 2.19 -5.94% 0.09 0.58 -84.48% -0.56 2.79 - 2.55 4.27 -40.28%

Description Sep 20 Sep 19 Var% Jun 20 Jun 19 Var% Mar 20 Mar 19 Var% Dec 19 Dec 18 Var%
Net Sales 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Expenses 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBITDA 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
EBIDTM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Other Income 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Depreciation 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PBT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Tax 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PAT 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
PATM 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
EPS 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00

Annual Results

Standalone Figures in Rs. Crores

Description TTM Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Net Sales 100.50 112.87 97.02 59.55 56.70 42.32 25.33 21.28 15.08 11.68 7.97 Net Sales Growth -15.55% 16.34% 62.92% 5.03% 33.98% 67.07% 19.03% 41.11% 29.11% 46.55% Cost Of Goods Sold 67.16 80.82 59.88 39.51 24.57 19.04 15.31 9.73 6.72 5.41 3.52 Gross Profit 33.34 32.06 37.14 20.04 32.12 23.29 10.02 11.56 8.36 6.27 4.45 GP Margin 33.17% 28.40% 38.28% 33.65% 56.65% 55.03% 39.56% 54.32% 55.44% 53.68% 55.83% Total Expenditure 91.38 104.54 86.79 53.84 53.37 38.42 23.67 19.85 13.69 11.38 7.21 Power & Fuel Cost - 3.10 2.75 1.60 1.64 1.17 0.84 0.62 0.58 0.45 0.35 % Of Sales - 2.75% 2.83% 2.69% 2.89% 2.76% 3.32% 2.91% 3.85% 3.85% 4.39% Employee Cost - 8.95 8.04 5.19 4.92 3.83 3.22 2.84 2.03 1.63 1.28 % Of Sales - 7.93% 8.29% 8.72% 8.68% 9.05% 12.71% 13.35% 13.46% 13.96% 16.06% Manufacturing Exp. - 4.55 4.07 1.21 15.32 9.47 0.72 3.38 2.39 2.53 1.08 % Of Sales - 4.03% 4.20% 2.03% 27.02% 22.38% 2.84% 15.88% 15.85% 21.66% 13.55% General & Admin Exp. - 5.15 7.09 3.57 3.34 1.93 1.70 1.50 0.41 0.35 0.50 % Of Sales - 4.56% 7.31% 5.99% 5.89% 4.56% 6.71% 7.05% 2.72% 3.00% 6.27% Selling & Distn. Exp. - 1.76 2.59 2.54 3.46 2.71 1.64 0.47 0.02 0.03 0.23 % Of Sales - 1.56% 2.67% 4.27% 6.10% 6.40% 6.47% 2.21% 0.13% 0.26% 2.89% Miscellaneous Exp. - 0.22 2.37 0.21 0.11 0.27 0.24 1.32 1.55 0.99 0.23 % Of Sales - 0.19% 2.44% 0.35% 0.19% 0.64% 0.95% 6.20% 10.28% 8.48% 3.26% EBITDA 9.12 8.33 10.23 5.71 3.33 3.90 1.66 1.43 1.39 0.30 0.76 EBITDA Margin 9.07% 7.38% 10.54% 9.59% 5.87% 9.22% 6.55% 6.72% 9.22% 2.57% 9.54% Other Income 0.00 0.52 0.38 0.16 1.91 0.86 0.49 0.36 0.34 0.72 0.26 Interest 3.81 4.47 3.12 1.95 1.87 2.06 1.05 0.81 0.88 0.85 0.64 Depreciation 1.90 1.88 1.33 1.29 1.14 0.80 0.55 0.53 0.49 0.35 0.32 PBT 2.26 2.49 6.16 2.64 2.23 1.90 0.55 0.45 0.36 -0.19 0.06 Tax 0.59 0.59 1.70 0.89 0.80 0.77 0.26 0.21 0.04 0.00 0.04 Tax Rate 26.11% 23.69% 27.60% 33.71% 35.87% 41.85% 50.00% 46.67% 80.00% 0.00% 66.67% PAT 1.67 1.90 4.46 1.75 1.43 1.07 0.26 0.24 0.01 -0.24 0.02 PAT before Minority Interest 1.67 1.90 4.46 1.75 1.43 1.07 0.26 0.24 0.01 -0.24 0.02 Minority Interest 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 PAT Margin 1.66% 1.68% 4.60% 2.94% 2.52% 2.53% 1.03% 1.13% 0.07% -2.05% 0.25% PAT Growth -57.61% -57.40% 154.86% 22.38% 33.64% 311.54% 8.33% 2300% 104.17% -1300% Unadjusted EPS 4.18 4.75 11.15 4.38 3.58 2.68 0.65 0.60 0.03 -0.60 0.05

Description

TTM

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Net Sales

100.50

112.87

97.02

59.55

56.70

42.32

25.33

21.28

15.08

11.68

7.97

Net Sales Growth

-15.55%

16.34%

62.92%

5.03%

33.98%

67.07%

19.03%

41.11%

29.11%

46.55%

Cost Of Goods Sold

67.16

80.82

59.88

39.51

24.57

19.04

15.31

9.73

6.72

5.41

3.52

Gross Profit

33.34

32.06

37.14

20.04

32.12

23.29

10.02

11.56

8.36

6.27

4.45

GP Margin

33.17%

28.40%

38.28%

33.65%

56.65%

55.03%

39.56%

54.32%

55.44%

53.68%

55.83%

Total Expenditure

91.38

104.54

86.79

53.84

53.37

38.42

23.67

19.85

13.69

11.38

7.21

Power & Fuel Cost

3.10

2.75

1.60

1.64

1.17

0.84

0.62

0.58

0.45

0.35

% Of Sales

2.75%

2.83%

2.69%

2.89%

2.76%

3.32%

2.91%

3.85%

4.39%

Employee Cost

8.95

8.04

5.19

4.92

3.83

3.22

2.84

2.03

1.63

1.28

% Of Sales

7.93%

8.29%

8.72%

8.68%

9.05%

12.71%

13.35%

13.46%

13.96%

16.06%

Manufacturing Exp.

4.55

4.07

1.21

15.32

9.47

0.72

3.38

2.39

2.53

1.08

% Of Sales

4.03%

4.20%

2.03%

27.02%

22.38%

2.84%

15.88%

15.85%

21.66%

13.55%

General & Admin Exp.

5.15

7.09

3.57

3.34

1.93

1.70

1.50

0.41

0.35

0.50

% Of Sales

4.56%

7.31%

5.99%

5.89%

4.56%

6.71%

7.05%

2.72%

3.00%

6.27%

Selling & Distn. Exp.

1.76

2.59

2.54

3.46

2.71

1.64

0.47

0.02

0.03

0.23

% Of Sales

1.56%

2.67%

4.27%

6.10%

6.40%

6.47%

2.21%

0.13%

0.26%

2.89%

Miscellaneous Exp.

0.22

2.37

0.21

0.11

0.27

0.24

1.32

1.55

0.99

0.23

% Of Sales

0.19%

2.44%

0.35%

0.19%

0.64%

0.95%

6.20%

10.28%

8.48%

3.26%

EBITDA

9.12

8.33

10.23

5.71

3.33

3.90

1.66

1.43

1.39

0.30

0.76

EBITDA Margin

9.07%

7.38%

10.54%

9.59%

5.87%

9.22%

6.55%

6.72%

9.22%

2.57%

9.54%

Other Income

0.00

0.52

0.38

0.16

1.91

0.86

0.49

0.36

0.34

0.72

0.26

Interest

3.81

4.47

3.12

1.95

1.87

2.06

1.05

0.81

0.88

0.85

0.64

Depreciation

1.90

1.88

1.33

1.29

1.14

0.80

0.55

0.53

0.49

0.35

0.32

PBT

2.26

2.49

6.16

2.64

2.23

1.90

0.55

0.45

0.36

-0.19

0.06

Tax

0.59

1.70

0.89

0.80

0.77

0.26

0.21

0.04

0.00

0.04

Tax Rate

26.11%

23.69%

27.60%

33.71%

35.87%

41.85%

50.00%

46.67%

80.00%

0.00%

66.67%

PAT

1.67

1.90

4.46

1.75

1.43

1.07

0.26

0.24

0.01

-0.24

0.02

PAT before Minority Interest

1.67

1.90

4.46

1.75

1.43

1.07

0.26

0.24

0.01

-0.24

0.02

Minority Interest

0.00

PAT Margin

1.66%

1.68%

4.60%

2.94%

2.52%

2.53%

1.03%

1.13%

0.07%

-2.05%

0.25%

PAT Growth

-57.61%

-57.40%

154.86%

22.38%

33.64%

311.54%

8.33%

2300%

104.17%

-1300%

Unadjusted EPS

4.18

4.75

11.15

4.38

3.58

2.68

0.65

0.60

0.03

-0.60

0.05

Results Balance Sheet

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Shareholder's Funds 41.32 38.99 22.16 7.26 3.96 3.08 2.85 2.64 2.66 2.94 Share Capital 3.99 3.99 3.43 4.87 2.62 2.62 2.62 2.62 2.62 2.62 Total Reserves 37.33 35.00 18.74 2.39 1.34 0.46 0.23 0.01 0.03 0.31 Non-Current Liabilities 14.07 12.51 4.06 8.37 7.31 3.69 2.69 1.83 2.01 2.20 Secured Loans 11.50 10.64 0.00 0.00 0.00 0.00 1.97 1.22 1.45 1.64 Unsecured Loans 0.00 0.00 0.00 7.24 6.19 2.94 0.03 0.00 0.00 0.00 Long Term Provisions 1.63 1.08 3.25 0.28 0.43 0.21 0.21 0.18 0.14 0.13 Current Liabilities 77.78 53.41 53.04 40.47 31.93 16.22 12.11 10.27 8.16 4.84 Trade Payables 44.19 33.70 38.92 22.83 16.27 6.99 5.10 3.21 3.73 1.41 Other Current Liabilities 7.61 8.94 1.33 7.75 7.18 2.82 1.91 3.49 1.26 0.98 Short Term Borrowings 23.41 8.63 9.90 7.58 6.85 5.10 4.38 3.30 2.98 2.29 Short Term Provisions 2.57 2.13 2.89 2.31 1.62 1.31 0.72 0.27 0.19 0.16 Total Liabilities 133.17 104.91 79.26 56.10 43.20 22.99 17.65 14.74 12.83 9.98 Net Block 30.97 31.35 16.28 20.50 14.51 7.92 7.02 6.02 5.66 5.19 Gross Block 36.61 35.11 25.00 27.93 20.80 13.40 12.10 10.58 9.83 8.94 Accumulated Depreciation 5.64 3.76 8.71 7.43 6.29 5.49 5.08 4.56 4.17 3.75 Non Current Assets 32.05 32.39 27.78 20.85 14.92 9.81 7.69 7.20 6.61 5.86 Capital Work in Progress 0.00 0.00 11.15 0.00 0.00 1.41 0.00 0.00 0.00 0.00 Non Current Investment 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Long Term Loans & Adv. 1.08 1.03 0.35 0.35 0.31 0.48 0.67 0.21 0.16 0.05 Other Non Current Assets 0.00 0.00 0.00 0.00 0.11 0.00 0.00 0.96 0.79 0.62 Current Assets 101.11 72.52 51.48 35.24 28.28 13.08 9.96 7.55 6.22 4.11 Current Investments 0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Inventories 50.46 40.78 18.43 6.94 10.27 4.29 3.58 3.25 2.77 1.23 Sundry Debtors 32.79 17.78 15.26 20.38 11.40 5.19 3.43 1.96 1.67 1.22 Cash & Bank 3.06 1.47 1.45 0.75 1.39 0.60 0.42 0.57 0.34 0.36 Other Current Assets 14.75 11.74 8.65 0.87 5.22 3.00 2.54 1.77 1.45 1.30 Short Term Loans & Adv. 0.90 0.75 7.70 6.31 5.01 1.05 0.59 1.77 1.45 1.30 Net Current Assets 23.33 19.11 -1.56 -5.23 -3.65 -3.14 -2.14 -2.72 -1.94 -0.73 Total Assets 133.16 104.91 79.26 56.09 43.20 23.00 17.65 14.75 12.83 9.97

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Shareholder's Funds

41.32

38.99

22.16

7.26

3.96

3.08

2.85

2.64

2.66

2.94

Share Capital

3.99

3.43

4.87

2.62

Total Reserves

37.33

35.00

18.74

2.39

1.34

0.46

0.23

0.01

0.03

0.31

Non-Current Liabilities

14.07

12.51

4.06

8.37

7.31

3.69

2.69

1.83

2.01

2.20

Secured Loans

11.50

10.64

0.00

1.97

1.22

1.45

1.64

Unsecured Loans

0.00

7.24

6.19

2.94

0.03

0.00

Long Term Provisions

1.63

1.08

3.25

0.28

0.43

0.21

0.18

0.14

0.13

Current Liabilities

77.78

53.41

53.04

40.47

31.93

16.22

12.11

10.27

8.16

4.84

Trade Payables

44.19

33.70

38.92

22.83

16.27

6.99

5.10

3.21

3.73

1.41

Other Current Liabilities

7.61

8.94

1.33

7.75

7.18

2.82

1.91

3.49

1.26

0.98

Short Term Borrowings

23.41

8.63

9.90

7.58

6.85

5.10

4.38

3.30

2.98

2.29

Short Term Provisions

2.57

2.13

2.89

2.31

1.62

1.31

0.72

0.27

0.19

0.16

Total Liabilities

133.17

104.91

79.26

56.10

43.20

22.99

17.65

14.74

12.83

9.98

Net Block

30.97

31.35

16.28

20.50

14.51

7.92

7.02

6.02

5.66

5.19

Gross Block

36.61

35.11

25.00

27.93

20.80

13.40

12.10

10.58

9.83

8.94

Accumulated Depreciation

5.64

3.76

8.71

7.43

6.29

5.49

5.08

4.56

4.17

3.75

Non Current Assets

32.05

32.39

27.78

20.85

14.92

9.81

7.69

7.20

6.61

5.86

Capital Work in Progress

0.00

11.15

0.00

1.41

0.00

Non Current Investment

0.00

Long Term Loans & Adv.

1.08

1.03

0.35

0.31

0.48

0.67

0.21

0.16

0.05

Other Non Current Assets

0.00

0.11

0.00

0.96

0.79

0.62

Current Assets

101.11

72.52

51.48

35.24

28.28

13.08

9.96

7.55

6.22

4.11

Current Investments

0.05

0.00

Inventories

50.46

40.78

18.43

6.94

10.27

4.29

3.58

3.25

2.77

1.23

Sundry Debtors

32.79

17.78

15.26

20.38

11.40

5.19

3.43

1.96

1.67

1.22

Cash & Bank

3.06

1.47

1.45

0.75

1.39

0.60

0.42

0.57

0.34

0.36

Other Current Assets

14.75

11.74

8.65

0.87

5.22

3.00

2.54

1.77

1.45

1.30

Short Term Loans & Adv.

0.90

0.75

7.70

6.31

5.01

1.05

0.59

1.77

1.45

1.30

Net Current Assets

23.33

19.11

-1.56

-5.23

-3.65

-3.14

-2.14

-2.72

-1.94

-0.73

Total Assets

133.16

104.91

79.26

56.09

43.20

23.00

17.65

14.75

12.83

9.97

Cash Flow

Standalone Figures in Rs. Crores

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Cash From Operating Activity -10.64 0.84 17.30 3.97 3.33 1.78 -0.68 1.30 0.00 0.00 PBT 2.35 6.18 1.75 2.23 1.83 0.52 0.45 0.36 0.00 0.00 Adjustment 6.03 2.08 2.67 2.64 2.35 1.41 0.37 0.61 0.00 0.00 Changes in Working Capital -19.02 -7.43 12.88 -0.25 -0.25 0.11 -1.51 0.65 0.00 0.00 Cash after chg. in Working capital -10.64 0.84 17.30 4.61 3.93 2.05 -0.68 1.61 0.00 0.00 Interest Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Tax Paid 0.00 0.00 0.00 -0.64 -0.60 -0.26 0.00 0.00 0.00 0.00 Other Direct Exp. Paid 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Extra & Other Items 0.00 0.00 0.00 0.00 0.00 0.00 0.00 -0.31 0.00 0.00 Cash From Investing Activity -1.49 -5.25 -8.21 -7.13 -5.99 -3.00 -1.52 -0.89 0.00 0.00 Net Fixed Assets -1.50 1.04 -8.22 -7.13 -5.99 -2.71 -1.52 -0.75 -0.89 -0.64 Net Investments -0.05 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 Others 0.06 -6.29 0.01 0.00 0.00 -0.29 0.00 -0.14 0.89 0.64 Cash from Financing Activity 13.73 4.43 -8.38 2.52 3.45 1.40 2.05 -0.18 0.00 0.00 Net Cash Inflow / Outflow 1.59 0.01 0.70 -0.64 0.79 0.18 -0.15 0.23 0.00 0.00 Opening Cash & Equivalents 1.47 1.45 0.75 1.39 0.60 0.42 0.57 0.34 0.00 0.00 Closing Cash & Equivalent 3.06 1.47 1.45 0.75 1.39 0.60 0.42 0.57 0.00 0.00

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Cash From Operating Activity

-10.64

0.84

17.30

3.97

3.33

1.78

-0.68

1.30

0.00

PBT

2.35

6.18

1.75

2.23

1.83

0.52

0.45

0.36

0.00

Adjustment

6.03

2.08

2.67

2.64

2.35

1.41

0.37

0.61

0.00

Changes in Working Capital

-19.02

-7.43

12.88

-0.25

0.11

-1.51

0.65

0.00

Cash after chg. in Working capital

-10.64

0.84

17.30

4.61

3.93

2.05

-0.68

1.61

0.00

Interest Paid

0.00

Tax Paid

0.00

-0.64

-0.60

-0.26

0.00

Other Direct Exp. Paid

0.00

Extra & Other Items

0.00

-0.31

0.00

Cash From Investing Activity

-1.49

-5.25

-8.21

-7.13

-5.99

-3.00

-1.52

-0.89

0.00

Net Fixed Assets

-1.50

1.04

-8.22

-7.13

-5.99

-2.71

-1.52

-0.75

-0.89

-0.64

Net Investments

-0.05

0.00

Others

0.06

-6.29

0.01

0.00

-0.29

0.00

-0.14

0.89

0.64

Cash from Financing Activity

13.73

4.43

-8.38

2.52

3.45

1.40

2.05

-0.18

0.00

Net Cash Inflow / Outflow

1.59

0.01

0.70

-0.64

0.79

0.18

-0.15

0.23

0.00

Opening Cash & Equivalents

1.47

1.45

0.75

1.39

0.60

0.42

0.57

0.34

0.00

Closing Cash & Equivalent

3.06

1.47

1.45

0.75

1.39

0.60

0.42

0.57

0.00

Financial Ratios

Standalone

Description Mar 20 Mar 19 Mar 18 Mar 17 Mar 16 Mar 15 Mar 14 Mar 13 Mar 12 Mar 11
Book Value (Rs.) 103.57 97.73 64.71 20.14 15.68 11.50 10.97 10.06 10.13 11.25 ROA 1.60% 4.84% 2.59% 2.88% 3.23% 1.26% 1.50% 0.05% -2.10% 0.24% ROE 4.74% 14.59% 13.02% 33.88% 33.46% 9.68% 9.79% 0.31% -9.51% 0.84% ROCE 10.36% 20.56% 15.90% 18.16% 24.67% 14.23% 14.50% 12.40% 8.47% 10.37% Fixed Asset Turnover 3.15 3.23 2.25 2.33 2.47 1.99 1.91 1.48 1.24 0.93 Receivable days 81.78 62.16 109.23 102.30 71.54 62.01 45.29 43.84 45.08 54.75 Inventory Days 147.53 111.37 77.73 55.39 62.77 56.62 57.45 72.77 62.49 54.33 Payable days 137.68 158.18 217.97 146.17 106.16 100.73 86.87 103.06 83.94 77.91 Cash Conversion Cycle 91.62 15.35 -31.02 11.52 28.15 17.90 15.87 13.55 23.63 31.17 Total Debt/Equity 0.84 0.49 0.45 2.53 3.92 3.06 2.49 1.84 1.83 1.41 Interest Cover 1.56 2.97 2.36 2.19 1.89 1.50 1.56 1.05 0.72 1.09

Description

Mar 20

Mar 19

Mar 18

Mar 17

Mar 16

Mar 15

Mar 14

Mar 13

Mar 12

Mar 11

Book Value (Rs.)

103.57

97.73

64.71

20.14

15.68

11.50

10.97

10.06

10.13

11.25

ROA

1.60%

4.84%

2.59%

2.88%

3.23%

1.26%

1.50%

0.05%

-2.10%

0.24%

ROE

4.74%

14.59%

13.02%

33.88%

33.46%

9.68%

9.79%

0.31%

-9.51%

0.84%

ROCE

10.36%

20.56%

15.90%

18.16%

24.67%

14.23%

14.50%

12.40%

8.47%

10.37%

Fixed Asset Turnover

3.15

3.23

2.25

2.33

2.47

1.99

1.91

1.48

1.24

0.93

Receivable days

81.78

62.16

109.23

102.30

71.54

62.01

45.29

43.84

45.08

54.75

Inventory Days

147.53

111.37

77.73

55.39

62.77

56.62

57.45

72.77

62.49

54.33

Payable days

137.68

158.18

217.97

146.17

106.16

100.73

86.87

103.06

83.94

77.91

Cash Conversion Cycle

91.62

15.35

-31.02

11.52

28.15

17.90

15.87

13.55

23.63

31.17

Total Debt/Equity

0.84

0.49

0.45

2.53

3.92

3.06

2.49

1.84

1.83

1.41

Interest Cover

1.56

2.97

2.36

2.19

1.89

1.50

1.56

1.05

0.72

1.09

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 539730 | NSE: Not Listed

Stock Summary

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update

Fredun Pharmaceuticals Ltd.

Pharmaceuticals & Drugs

BSE: 539730 | NSE: Not Listed

Stock Summary

Shareholding Pattern

Chart

Price | P:E | P:BV | EV:EBITDA

Revenue CAGR (%)

EBITDA CAGR (%)

PAT CAGR (%)

P:E (Median)

P:BV (Average)

EV:EBITDA (Average)

Quarterly Results

Standalone Figures in Rs. Crores

Annual Results

Standalone Figures in Rs. Crores

Results Balance Sheet

Standalone Figures in Rs. Crores

Cash Flow

Standalone Figures in Rs. Crores

Financial Ratios

Standalone

Annual Reports:

News Update